These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35028929)

  • 21. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma.
    He T; Lu C; Gong W; Ge Z; Li R; Li X; Sun C; Li W; Long Q; Liu Q; Lai Y
    Front Biosci (Landmark Ed); 2024 May; 29(5):186. PubMed ID: 38812297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
    Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
    Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
    Güllü Amuran G; Tinay I; Filinte D; Ilgin C; Peker Eyüboğlu I; Akkiprik M
    Int Urol Nephrol; 2020 Mar; 52(3):461-468. PubMed ID: 31679136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A panel of three serum microRNA can be used as potential diagnostic biomarkers for nasopharyngeal carcinoma.
    Li R; Lu C; Yang W; Zhou Y; Zhong J; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Hu H; Lai Y
    J Clin Lab Anal; 2022 Feb; 36(2):e24194. PubMed ID: 35028969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on identification of a three-microRNA panel in serum for diagnosing neonatal early onset sepsis.
    Zhao Y; Lu C; Zhu R; Hu X
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2280527. PubMed ID: 37968923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between microRNAs and bladder cancer: are microRNAs useful to predict bladder cancer in suspicious patients?
    Kaba M; Pirinççi N; Demir M; Kaba S; Oztuzcu S; Verep S
    Int Urol Nephrol; 2023 Oct; 55(10):2483-2491. PubMed ID: 37338656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma.
    Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L
    Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
    Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
    Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
    Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
    Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a four-microRNA panel in serum for screening renal cell carcinoma.
    Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
    Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
    Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
    J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating miRNAs in Untreated Breast Cancer: An Exploratory Multimodality Morpho-Functional Study.
    Incoronato M; Grimaldi AM; Mirabelli P; Cavaliere C; Parente CA; Franzese M; Staibano S; Ilardi G; Russo D; Soricelli A; Catalano OA; Salvatore M
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools.
    Canturk KM; Ozdemir M; Can C; Öner S; Emre R; Aslan H; Cilingir O; Ciftci E; Celayir FM; Aldemir O; Özen M; Artan S
    Mol Biol Rep; 2014 Dec; 41(12):8127-35. PubMed ID: 25189652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five serum microRNAs for detection and predicting of ovarian cancer.
    Wang W; Wu LR; Li C; Zhou X; Liu P; Jia X; Chen Y; Zhu W
    Eur J Obstet Gynecol Reprod Biol X; 2019 Jul; 3():100017. PubMed ID: 31404211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    Du L; Jiang X; Duan W; Wang R; Wang L; Zheng G; Yan K; Wang L; Li J; Zhang X; Pan H; Yang Y; Wang C
    Oncotarget; 2017 Jun; 8(25):40832-40842. PubMed ID: 28388561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.